Zobrazeno 1 - 10
of 129
pro vyhledávání: '"Adj Pearson"'
Autor:
Rebecca Roylance, Alba Llop-Guevara, Serena Nik-Zainal, Neha Chopra, Helen Davies, Andrew Tutt, Anthony Skene, Divya Kriplani, Nicholas C. Turner, Heidrun Gevensleben, Judith M Bliss, Marta Castroviejo-Bermejo, C. Toms, V. Serra Elizalde, Cristina Cruz, Steve Chan, Holly Tovey, Abigail Evans, J. Balmaña, Adj Pearson
Publikováno v:
Annals of Oncology. 32:S21-S22
Autor:
Keith Wheatley, Bruce Morland, D. Murphy, N. van Eijkelenburg, Cormac Owens, Genevieve Laureys, Dominique Valteau-Couanet, L Moreno, Aurora Castellano, Nicolas U. Gerber, Veronica Moroz, Marion Gambart, Ruth Ladenstein, M. Elliott, Estelle Thebaud, Adj Pearson, Victoria Castel, Sucheta Vaidya, Karsten Nysom
Publikováno v:
Annals of Oncology. 30:v901
Background BEACON-Neuroblastoma is a randomized phase II trial to assess the activity of backbone chemotherapy regimens for children with RR-HRNB and to determine if inhibiting angiogenesis with bevacizumab adds to the activity of this chemotherapy.
Autor:
Mosseri, Peter F. Ambros, Gian Paolo Tonini, Edward F. Attiyeh, I.M. Ambros, Tom Monclair, Garrett M. Brodeur, Michelle Haber, Wendy B. London, Rosa Noguera, Javed Khan, Akira Nakagawara, Franki Speleman, Adj Pearson, Katherine K. Matthay, John M. Maris, Susan L. Cohn, Matthias Fischer, Gudrun Schleiermacher
Publikováno v:
British Journal of Cancer
Background: In the INRG dataset, the hypothesis that any segmental chromosomal alteration might be of prognostic impact in neuroblastoma without MYCN amplification (MNA) was tested. Methods: The presence of any segmental chromosomal alteration (chrom
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Marie Jeanne Pierrat, P. Bedard, Adj Pearson, Christine Campbell, C. Poirot, Philippe Aftimos, Giuseppe Curigliano, Fergus Daly, Jose Perez-Garcia, Amal Arahmani, S. Loibl, L. Xuereb, Debora Fumagalli, Nicholas C. Turner, Rina Hui, Matteo Lambertini, Fabrice Andre, Hatem A. Azim, Sherene Loi, J. Cortes Castan
Publikováno v:
Annals of Oncology. 29:viii93
Autor:
Javed Khan, Franki Speleman, Michelle Haber, Akira Nakagawara, Adj Pearson, Garrett M. Brodeur, Susan L. Cohn, John M. Maris, Wendy B. London, I.M. Ambros, Peter F. Ambros, Gudrun Schleiermacher, R Spitz
Publikováno v:
British Journal of Cancer
Neuroblastoma serves as a paradigm for utilising tumour genomic data for determining patient prognosis and treatment allocation. However, before the establishment of the International Neuroblastoma Risk Group (INRG) Task Force in 2004, international
Autor:
Alan V. Boddy, Christopher P.F. Redfern, Adj Pearson, M Ruiz, Gareth J. Veal, Jane L. Armstrong
Publikováno v:
British Journal of Cancer
Recent data indicate that isomerisation to all-trans retinoic acid (ATRA) is the key mechanism underlying the favourable clinical properties of 13-cis retinoic acid (13cisRA) in the treatment of neuroblastoma. Retinoic acid (RA) metabolism is thought
Autor:
Gareth J. Veal, Juliet Hale, Adj Pearson, E Price, Bruce Morland, E J Estlin, Annie Parry, MJ Griffin, S. M. Yule, Alan V. Boddy, H Welbank, Mark A. Little, G S Dick
Publikováno v:
British Journal of Cancer
Pre-clinical studies indicate that cisplatin encapsulated in STEALTH®liposomes (SPI-77) retains anti-tumour activity, but has a much reduced toxicity, compared to native cisplatin. A phase I study was conducted to determine the toxicity and pharmaco
Autor:
K. M. Kazemier, G. J. L. Kaspers, Adj Pearson, M L den Boer, U. Creutzig, A. J. P. Veerman, Günter Henze, Andrew G. Hall, Pamela Kearns, G. E. Janka-Schaub, R. Pieters
Publikováno v:
British Journal of Haematology. 104:321-327
Expression of three major classes of glutathione S-transferases (GSTs), i.e. alpha, mu and pi class, P-glycoprotein (P-gp) and multidrug resistance-associated protein (MRP) were studied in childhood acute lymphoblastic leukaemia (ALL), acute myeloid
Autor:
Pascale Reidenberg, A Marco, Ian Lewis, Adj Pearson, M Mott, S Ablett, Vijay Batra, C. Dicks-Mireaux, R. Gowing, Linda S Lashford, Bruce Morland, Richard F. Stevens, Mcg Stevens, CR Pinkerton, J.A. Kohler, Margaret Dugan, A Gholkar, D. Walker, L. Price, Heather P. McDowell, Paul Statkevich, EJ Estlin, Newell
Publikováno v:
British Journal of Cancer. 78:652-661
A phase I study of temozolomide administered orally once a day, on 5 consecutive days, between 500 and 1200 mg m(-2) per 28-day cycle was performed. Children were stratified according to prior craniospinal irradiation or nitrosourea therapy. Sixteen